Journal article
Treatment of Primary Biliary Cholangitis including Transplantation
Clinics in liver disease, Vol.28(1), pp.103-114
02/01/2024
DOI: 10.1016/j.cld.2023.07.003
PMID: 37945152
Abstract
Ursodeoxycholic acid (UDCA) is the first-line treatment of primary biliary cholangitis (PBC). Long-term UDCA use significantly reduces progression to cirrhosis. UDCA improves liver enzymes and transplant-free survival rates. Despite the association between PBC and hyperlipidemia, treatment is indicated under specific circumstances with statins and fibrates being safe options. Osteoporosis, which is frequently seen, is usually managed based on data from postmenopausal women. Sicca syndrome is treated similarly to its standalone condition with the use of hydroxypropyl methylcellulose eye drops and anticholinergic drugs.
Details
- Title: Subtitle
- Treatment of Primary Biliary Cholangitis including Transplantation
- Creators
- Yasameen Muzahim - Rutgers, The State University of New JerseyAli Wakil - Rutgers, The State University of New JerseyMehak Bassi - Saint Peter's University HospitalNikolaos Pyrsopoulos - Rutgers, The State University of New Jersey
- Resource Type
- Journal article
- Publication Details
- Clinics in liver disease, Vol.28(1), pp.103-114
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.cld.2023.07.003
- PMID
- 37945152
- ISSN
- 1089-3261
- eISSN
- 1557-8224
- Language
- English
- Date published
- 02/01/2024
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984695677002771
Metrics
4 Record Views